Gemcitabine for the treatment of metastatic breast cancer

  • Technology appraisal guidance
  • TA116
  • Published: 
Download guidance (PDF)

Update information

March 2014: Implementation section updated to clarify that gemcitabine is recommended as an option for treating metastatic breast cancer.

ISBN: 978-1-4731-7036-0